Cystatin E/M suppresses legumain activity and invasion of human melanoma

Overview of attention for article published in BMC Cancer, January 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 64 Dimensions

Readers on

mendeley: 61 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

CYSTATIN RNA COMPOSITIONS FOR TISSUE ENGINEERING

Application WO-2023130022-A3

World Intellectual Property Organisation (WIPO)

Inhibitors against endosomal/lysosomal enzymes

Grant US-9050374-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.